...
search icon
abbv-img

AbbVie Inc Share Price

ABBV
NYQ
$235.37
+$1.11
(0.47%)
1D
Industry: Biotechnology Sector: Health Care

AbbVie Inc Analyst Forecast

AbbVie Inc Share Price Chart

AbbVie Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$414.21B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
98.8439
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.95M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
2.87%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$159.05 L
$241.12 H
$235.37

About AbbVie Inc, Common Stock

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. more

Industry: BiotechnologySector: Health Care

AbbVie Inc Stock Returns

Time FrameABBVSectorS&P500
1-Week Return2.08%-0.01%0.58%
1-Month Return3.82%1.82%-1.31%
3-Month Return4.41%2.7%0.75%
6-Month Return10.54%15.24%7.23%
1-Year Return10.77%5.98%17.57%
3-Year Return51.74%24.1%72.72%
5-Year Return117.21%39.37%77.65%
10-Year Return320.57%133.96%245.87%

AbbVie Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue56.20B58.05B54.32B56.33B61.16B[{"date":"2021-12-31","value":91.89,"profit":true},{"date":"2022-12-31","value":94.92,"profit":true},{"date":"2023-12-31","value":88.81,"profit":true},{"date":"2024-12-31","value":92.11,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue17.45B17.41B20.41B16.90B9.96B[{"date":"2021-12-31","value":85.46,"profit":true},{"date":"2022-12-31","value":85.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":82.8,"profit":true},{"date":"2025-12-31","value":48.81,"profit":true}]
Gross Profit38.75B40.64B33.90B39.43B51.20B[{"date":"2021-12-31","value":75.69,"profit":true},{"date":"2022-12-31","value":79.38,"profit":true},{"date":"2023-12-31","value":66.22,"profit":true},{"date":"2024-12-31","value":77.02,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin68.96%70.00%62.42%69.99%83.71%[{"date":"2021-12-31","value":82.38,"profit":true},{"date":"2022-12-31","value":83.63,"profit":true},{"date":"2023-12-31","value":74.56,"profit":true},{"date":"2024-12-31","value":83.62,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Expenses20.83B22.52B21.15B30.29B29.98B[{"date":"2021-12-31","value":68.75,"profit":true},{"date":"2022-12-31","value":74.35,"profit":true},{"date":"2023-12-31","value":69.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":98.97,"profit":true}]
Operating Income17.92B18.12B12.76B9.14B21.21B[{"date":"2021-12-31","value":84.49,"profit":true},{"date":"2022-12-31","value":85.4,"profit":true},{"date":"2023-12-31","value":60.13,"profit":true},{"date":"2024-12-31","value":43.07,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(7.32B)(6.68B)(8.19B)(7.58B)(17.24B)[{"date":"2021-12-31","value":-731900000000,"profit":false},{"date":"2022-12-31","value":-668400000000,"profit":false},{"date":"2023-12-31","value":-819100000000,"profit":false},{"date":"2024-12-31","value":-758100000000,"profit":false},{"date":"2025-12-31","value":-1724400000000,"profit":false}]
Pre-Tax Income12.99B13.48B6.25B3.72B6.60B[{"date":"2021-12-31","value":96.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.38,"profit":true},{"date":"2024-12-31","value":27.57,"profit":true},{"date":"2025-12-31","value":48.95,"profit":true}]
Income Taxes1.44B1.63B1.38B(570.00M)2.36B[{"date":"2021-12-31","value":60.91,"profit":true},{"date":"2022-12-31","value":69.04,"profit":true},{"date":"2023-12-31","value":58.25,"profit":true},{"date":"2024-12-31","value":-24.11,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes11.55B11.85B4.87B4.29B4.23B[{"date":"2021-12-31","value":97.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.14,"profit":true},{"date":"2024-12-31","value":36.18,"profit":true},{"date":"2025-12-31","value":35.74,"profit":true}]
Income From Continuous Operations11.55B11.85B4.87B4.29B4.23B[{"date":"2021-12-31","value":97.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.14,"profit":true},{"date":"2024-12-31","value":36.18,"profit":true},{"date":"2025-12-31","value":35.74,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income11.54B11.84B4.86B4.28B4.23B[{"date":"2021-12-31","value":97.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.09,"profit":true},{"date":"2024-12-31","value":36.14,"profit":true},{"date":"2025-12-31","value":35.7,"profit":true}]
EPS (Diluted)12.6813.8711.1110.1210.00[{"date":"2021-12-31","value":91.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.1,"profit":true},{"date":"2024-12-31","value":72.96,"profit":true},{"date":"2025-12-31","value":72.1,"profit":true}]

AbbVie Inc Ratios

AbbVie Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ABBV
Cash Ratio 0.12
Current Ratio 0.67
Quick Ratio 0.56

AbbVie Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABBV
ROA (LTM) 9.81%
ROE (LTM) 62.25%

AbbVie Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABBV
Debt Ratio Lower is generally better. Negative is bad. 1.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.02

AbbVie Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABBV
Trailing PE 98.84
Forward PE 15.95
P/S (TTM) 6.77
P/B 50.46
Price/FCF 85
EV/R 7.73
EV/Ebitda 26.81
PEG 0.55

FAQs

What is AbbVie Inc share price today?

AbbVie Inc (ABBV) share price today is $235.37

Can Indians buy AbbVie Inc shares?

Yes, Indians can buy shares of AbbVie Inc (ABBV) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABBV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AbbVie Inc be purchased?

Yes, you can purchase fractional shares of AbbVie Inc (ABBV) via the Vested app. You can start investing in AbbVie Inc (ABBV) with a minimum investment of $1.

How to invest in AbbVie Inc shares from India?

You can invest in shares of AbbVie Inc (ABBV) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABBV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AbbVie Inc shares
What is AbbVie Inc 52-week high and low stock price?

The 52-week high price of AbbVie Inc (ABBV) is $241.12. The 52-week low price of AbbVie Inc (ABBV) is $159.05.

What is AbbVie Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AbbVie Inc (ABBV) is 98.8439

What is AbbVie Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AbbVie Inc (ABBV) is 50.46

What is AbbVie Inc dividend yield?

The dividend yield of AbbVie Inc (ABBV) is 2.87%

What is the Market Cap of AbbVie Inc?

The market capitalization of AbbVie Inc (ABBV) is $414.21B

What is AbbVie Inc's stock symbol?

The stock symbol (or ticker) of AbbVie Inc is ABBV

How Can Investors Use AbbVie Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of AbbVie Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether AbbVie Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from AbbVie Inc shares for Indian investors?

When investing in AbbVie Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the AbbVie Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare AbbVie Inc share price with other stocks in the same sector?

Rather than merely checking the share price of AbbVie Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that AbbVie Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top